Abstract 15611: Disparities in Hypertension Control Amidst the Pandemic: A Multi-Year Analysis Using Multiple Hospital Database

Abstract

Introduction: Hypertension, a pervasive global health concern, affects roughly half of US adults and can lead to serious health issues if uncontrolled. This study utilized the Epic Cosmos anonymized database to evaluate blood pressure (BP) control efficacy and related disparities among hypertensive patients from 196 healthcare institutions. Additionally, we explored the pandemic impact on these outcomes. Hypothesis: To evaluate blood pressure (BP) control efficacy and related disparities among hypertensive patients from 196 healthcare institutions using the Epic Cosmos anonymized database. Methods: Using the Epic Cosmos database, hypertension control rates from 2018 to 2022 were evaluated and stratified by patients' socio-demographic profiles. A multivariable logistic regression analysis identified factors associated with BP control rates. Results: In 2022, the study included 13.4 million hypertensive patients aged 18 and older. Of these, 66.0% achieved BP control (BP< 140/90 mm Hg), 31.0% reached stricter control (BP<130/80 mm Hg), and 7.0% had severely uncontrolled hypertension. Control rates were lower among Non-Hispanic Blacks (59.4%) compared to Non-Hispanic Whites (67.5%) with an adjusted odds ratio (AOR) of 0.749 (95% confidence interval (CI): 0.746-0.752). Self-pay patients were less likely to achieve control than insured patients (58.8% vs 66.8%, AOR: 0.79, 95% CI: 0.78-0.80). BP control rates fluctuated from 2018 to 2022, reflecting the pandemic's impact. Conclusions: The findings highlight suboptimal hypertension control rates and disparities in the US, emphasizing the need for tailored hypertension management initiatives. These should consider identified disparities and ensure accessibility and cultural sensitivity, aligning with the American Heart Association guidelines.